Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
Datametrex AI Limited reports developments across technology solutions, artificial intelligence and healthcare, with recurring updates tied to data centre operations, private cloud infrastructure and managed services for enterprise customers. Company announcements describe purchase orders for hyperconverged infrastructure software, technical support and AI-enabled resource optimization, including work delivered through Datametrex Korea.
News also covers the company's use of AI-assisted functionality in electronic medical records and the intellectual property activities of wholly owned subsidiary Paymetrex Payment Solutions Inc. Paymetrex updates include patent licensing and monetization initiatives involving secure transaction processing, payment authorization workflows, mobile-based acceptance architectures and potential relevance to SoftPOS and next-generation secure payment environments.
Datametrex (OTC:DTMXF) announced on November 27, 2025 that its subsidiary Datametrex Korea secured purchase orders totaling approximately CAD $650,000. The P.O.s represent roughly CAD $650,000 in new revenue with an approximate 20% gross profit margin. The company described the orders as part of its land and expand strategy and said they reinforce its role as an IT infrastructure solutions provider to major global partners.
The announcement highlights contribution from Korean operations and management commentary emphasizing continued partnership-driven growth and operational execution.
Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health added four new physicians and is accepting new patients in Calgary and Edmonton as of November 24, 2025.
Calgary clinics added Dr. Younis, Dr. Rezaeisarlak, and Dr. Fiselier to expand insured primary-care services under Alberta's provincial system. Edmonton clinic added Dr. Abdulkadir to increase capacity and access. The release lists clinic addresses, phone numbers, fax numbers, and Monday–Friday hours for booking appointments.
DataMetrex (OTC:DTMXF) announced that subsidiary Imagine Health Medical Clinics has reopened its Edmonton South clinic at 2551 Hewes Way NW, Suite 104, Edmonton, AB T6L 6W6. The new facility is open and accepting new patients seeking a family physician.
Clinic contact: (780) 468-5999, fax 1 (855) 751-0323. Hours: Monday–Friday, 8:30 AM–4:30 PM. Management said the relocation provides a modern, accessible space intended to support patient-focused care across Alberta.
Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health Medical Clinics has relocated its Calgary clinic to Capitol Hill and is now fully operational.
New address: 2004 14 Street NW, Suite 207, Calgary, Alberta T2M 3N3. Clinic hours are Monday–Friday, 8:30 AM–4:30 PM. Contact: (403) 775-9669 or fax 1 (866) 483-1816. The clinic is accepting new patients and bookings by phone or fax.
Datametrex (OTC:DTMXF) closed two financings on November 14, 2025, raising aggregate gross proceeds of $5,133,500 through a common share private placement (47,918,750 shares at $0.08; $3,833,500) and a subscription receipt financing (16,250,000 receipts at $0.08; $1,300,000).
The subscription proceeds are escrowed pending satisfaction of escrow release conditions tied to the proposed acquisition of the Yuzu Payment Solution, with an escrow release deadline of December 31, 2025. Proceeds will fund Yuzu integration, merchant opportunities, a new clinic location, and working capital. Finders fees total $130,000 cash plus 1,625,000 finders warrants for the subscription financing and cash and equity finders fees for the common placement. Insider Andrew Ryu acquired 16,250,000 shares (~16.65%).
Datametrex AI (TSXV:DM / FSE:D4G / OTC:DTMXF) announced it intends to close two financings on November 14, 2025: a non-brokered private placement and a subscription receipt financing.
The company plans to issue up to 50,000,000 common shares at $0.08 for gross proceeds up to $4,000,000, and up to 16,250,000 subscription receipts at $0.08 for gross proceeds up to $1,300,000, totaling up to $5,300,000 in gross proceeds.
Net proceeds are designated for business expansion, a new location, integration of the Yuzu Payment Solution into Datametrex's technology division, and general working capital. The company may pay finder's fees up to 5% cash, 5% shares and 10% warrants or alternatively up to 10% cash and 10% warrants. All securities will be subject to a statutory hold period of four months plus one day.
Datametrex AI (OTC:DTMXF) announced the immediate appointment of Mr. Enrico Moretti to its Board of Directors, effective October 24, 2025. Mr. Moretti is a securities lawyer with cross-border experience (called to the Ohio bar in 1997 and Ontario bar in 2000) and specializes in corporate and securities law, corporate finance transactions, governance, and regulatory compliance.
The appointment fulfills the Exchange's minimum director requirement and follows a trading halt the Exchange imposed while the company remedied the board deficiency. The company said it acted promptly, has notified the Exchange, and is working to restore normal trading and confirm continued listing compliance.
Datametrex AI (OTC:DTMXF) announced plans to upsize its previously announced non-brokered private placements. The company seeks to increase its common shares placement from $3 million to $4 million, and its subscription receipts offering from $1 million to $1.3 million.
The subscription receipts proceeds will fund the integration of Yuzu Payment Solution into Datametrex's technology division, pursue merchant opportunities, and provide working capital. The company may pay up to 10% finder's fees in cash and warrants for both offerings. All securities will have a four-month plus one-day hold period.
Datametrex AI (OTC:DTMXF) has confirmed the terms of two previously announced private placement financings. The company is conducting a non-brokered private placement of up to $3,000,000 in common shares and another private placement of up to $1,000,000 in subscription receipts.
Both offerings are priced at $0.08 per share/receipt. The subscription receipts' proceeds will fund the integration of Yuzu Payment Solution in Datametrex's technology division and pursue merchant opportunities. The company may pay finder's fees of up to 10% cash and 10% finder's warrants for the financings, though no finder's fees apply to the Yuzu acquisition.
Datametrex AI Limited (DTMXF) has signed a non-binding Letter of Intent to acquire the Yuzu payment processing solution from Firstpayment Inc. for approximately $5.5 million through the issuance of 55 million shares at $0.10 per share.
The Yuzu Payment Solution includes 8 US patents and 2 Canadian patents for cryptocurrency payment processing, enabling merchants to conduct secure crypto transactions. The acquisition includes Firstpayment's intellectual property and patents under the "YUZU" trademark. Following the acquisition, Firstpayment's CEO Michael Kron is expected to join Datametrex's management team and board.
The deal is subject to TSXV approval and includes a planned $1 million non-brokered private placement of subscription receipts. Firstpayment's unaudited financials show intangible assets of $2.3 million as of June 30, 2025, with the company having incurred a net loss of $254,546 for the previous 12 months.